On Wednesday, July 31, Acting Chief Financial Officer of the USPTO Sean Mildrew posted an announcement on the USPTO’s blog explaining the Office’s reasoning for its proposal to raise patent fees in a number of areas. The increase will enhance quality and timeliness of examination, America Invents Act (AIA) trials, and replenish the patent operations reserve to stabilize the Office’s finance, Mildrew said. According to the Notice of Proposed Rulemaking, at least part of the need for the proposed increase is due to the fact that patent application filings are down. “Actual Utility, Plant, and Reissue (UPR) application filings in FYs 2017 and 2018 were less robust than expected,” said the Notice. “In the FY 2020 Budget, given the lower than expected previous year filings, and an analysis of domestic and global economic forecasts, the USPTO has lowered future year filing projections from what was expected when the January 2018 Final Rule was published.”
Recent Posts
- Other Barks & Bites for Friday, May 9: USPTO Responds to GAO Report; Stewart Welcomes National Inventors Hall of Fame Inductees; CAFC Defines ‘Ground’ for IPR Estoppel Statute
- PTAB Designates as Informative Stewart Decision on Discretion to Institute in Context of Parallel District Court Litigation
- Judge Hughes Again Calls Out CAFC’s Overly Rigid Article III Analysis for Pharmaceutical Cases
- Coke Stewart’s Recent Show Cause Order Offers Hope for Addressing Serial Patent Challenges
- The USPTO Should Reintroduce the AFCP Program—Now